Surgical Management of Hepatic Benign Disease: Have the Number of Liver Resections Increased in the Era of Minimally Invasive Approach? Analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry.
Benign liver disease
Benign liver tumors
Indications for resection
Laparoscopic liver resection
Minimally invasive liver surgery
Operative risk
Journal
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
ISSN: 1873-4626
Titre abrégé: J Gastrointest Surg
Pays: United States
ID NLM: 9706084
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
03
02
2019
accepted:
01
05
2019
pubmed:
12
9
2019
medline:
15
4
2021
entrez:
12
9
2019
Statut:
ppublish
Résumé
Increased expertise with minimally invasive liver surgery (MILS) could cause an unjustified extension of indications to resect liver benign disease (BD). The aim of this study was to evaluate the operative risk of MILS for BD and if implementation and diffusion of MILS have widened indications for BD resection. A prospective study including centers with > 6 MILS for BD, enrolled in the I Go MILS registry from January 2015 to October 2016. Cysts fenestrations were excluded. Eight hundred eighteen MILS were performed in 15 centers. One hundred seventy-three of these (21.1%) were for BD: conversion rate was 6.9%, postoperative mortality and morbidity rates were 0 and 13.9%. During the same period, 3713 liver resections (open + MILS) were performed and 407 (11.0%) were for BD. A time-trend analysis showed that the total number of MILS and the number of MILS for malignant disease significantly increased, but this increasing trend was not documented for the number of MILS for BD, which remained stable during the study period of time. This trend was confirmed for the overall rate of resected BD (open + MILS) that remained stable. BD represents a valid indication for MILS. For BD, 21.1% of MILS was performed, rate significantly lower than that previously reported in Italy. Although an evident growth of the use of MILS was observed during the time period analysis in Italy, this trend did not correspond to an increased number of MILS for BD, and the overall rate of resected BD was comparable to that reported in previous large open series.
Sections du résumé
BACKGROUND
Increased expertise with minimally invasive liver surgery (MILS) could cause an unjustified extension of indications to resect liver benign disease (BD). The aim of this study was to evaluate the operative risk of MILS for BD and if implementation and diffusion of MILS have widened indications for BD resection.
METHODS
A prospective study including centers with > 6 MILS for BD, enrolled in the I Go MILS registry from January 2015 to October 2016. Cysts fenestrations were excluded.
RESULTS
Eight hundred eighteen MILS were performed in 15 centers. One hundred seventy-three of these (21.1%) were for BD: conversion rate was 6.9%, postoperative mortality and morbidity rates were 0 and 13.9%. During the same period, 3713 liver resections (open + MILS) were performed and 407 (11.0%) were for BD. A time-trend analysis showed that the total number of MILS and the number of MILS for malignant disease significantly increased, but this increasing trend was not documented for the number of MILS for BD, which remained stable during the study period of time. This trend was confirmed for the overall rate of resected BD (open + MILS) that remained stable.
DISCUSSION
BD represents a valid indication for MILS. For BD, 21.1% of MILS was performed, rate significantly lower than that previously reported in Italy. Although an evident growth of the use of MILS was observed during the time period analysis in Italy, this trend did not correspond to an increased number of MILS for BD, and the overall rate of resected BD was comparable to that reported in previous large open series.
Identifiants
pubmed: 31506894
doi: 10.1007/s11605-019-04260-7
pii: 10.1007/s11605-019-04260-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2233-2243Références
Chiche L, Adam JP. Diagnosis and management of benign liver tumors. Sem Liver Dis 2013; 33: 236–247.
doi: 10.1055/s-0033-1351779
Ehrl D, Rothaug K, Herzog P, Hofer B, Rau HG. “Incidentaloma” of the liver: management of a diagnostic and therapeutic dilemma. HPB Surg 2012; 2012: 891787.
doi: 10.1155/2012/891787
Belghiti J, Cauchy F, Paradis V, Vilgrain V. Diagnosis and management of solid benign liver lesions. Nat Rev Gastroenterol Hepatol 2014; 11 (12): 737–749.
doi: 10.1038/nrgastro.2014.151
Bieze M, van den Esschert JW, Nio CY, Verheij J, Reitsma JB, Terpstra V, van Gulik TM, Phoa SS. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. AJR Am J Roentgenol 2012; 199 (1): 26–34.
doi: 10.2214/AJR.11.7750
McInnes MD, Hibbert RM, Inácio JR, Schieda N. Focal Nodular Hyperplasia and Hepatocellular Adenoma: Accuracy of Gadoxetic Acid-enhanced MR Imaging--A Systematic Review. Radiology 2015; 277 (2): 413–423.
doi: 10.1148/radiol.2015142986
Mezhir JJ, Fourman LT, Do RK, Denton B, Allen PJ, D'Angelica MI, DeMatteo RP, Fong Y, Jarnagin WR. Changes in the management of benign liver tumours: an analysis of 285 patients. HPB (Oxford) 2013; 15 (2): 156–163.
doi: 10.1111/j.1477-2574.2012.00556.x
Dardenne S, Hubert C, Sempoux C, Annet L, Jouret-Mourin A, Horsmans Y, Van Beers BE, Zech F, Gigot JF. Conservative and operative management of benign solid hepatic tumours: a successful stratified algorithm. Eur J Gastroenterol Hepatol 2010; 22 (11): 1337–1344.
doi: 10.1097/MEG.0b013e32833db907
Hau HM, Kloss A, Wiltberger G, Jahn N, Krenzien F, Benzing C, Schmelzle M, Seehofer D, Atanasov G, Bartels M. The challenge of liver resection in benign solid liver tumors in modern times - in which cases should surgery be done? Z Gastroenterol 2017; 55 (7): 639–652.
doi: 10.1055/s-0043-110145
Kneuertz PJ, Marsh JW, de Jong MC, Covert K, Hyder O, Hirose K, Schulick RD, Choti MA, Geller DA, Pawlik TM. Improvements in quality of life after surgery for benign hepatic tumors: Results from a dual center analysis. Surgery 2012; 152 (2): 193–201.
doi: 10.1016/j.surg.2012.05.004
Giuliante F, Ardito F, Vellone M, Giordano M, Ranucci G, Piccoli M, Giovannini I, Chiarla C, Nuzzo G. Reappraisal of surgical indications and approach for liver hemangioma: single-center experience on 74 patients. Am J Surg 2011; 201 (6): 741–748.
doi: 10.1016/j.amjsurg.2010.03.007
Ardito F, Tayar C, Laurent A, Karoui M, Loriau J, Cherqui D. Laparoscopic liver resection for benign disease. Arch Surg 2007; 142 (12): 1188–1193.
doi: 10.1001/archsurg.142.12.1188
Troisi R, Montalti R, Smeets P, Van Huysse J, Van Vlierberghe H, Colle I, De Gendt S, de Hemptinne B. The value of laparoscopic liver surgery for solid benign hepatic tumors. Surg Endosc 2008; 22 (1): 38–44.
doi: 10.1007/s00464-007-9527-y
Buell JF, Tranchart H, Cannon R, Dagher I. Management of benign hepatic tumors. Surg Clin North Am 2010; 90 (4): 719–735.
doi: 10.1016/j.suc.2010.04.006
Abu Hilal M, Di Fabio F, Teng MJ, Godfrey DA, Primrose JN, Pearce NW. Surgical management of benign and indeterminate hepatic lesions in the era of laparoscopic liver surgery. Dig Surg 2011; 28 (3): 232–236.
doi: 10.1159/000321891
Singhal A, Huang Y, Kohli V. Laparoscopic liver resection for benign and malignant liver tumors. Hepatobiliary Pancreat Dis Int 2011; 10 (1): 38–42.
doi: 10.1016/S1499-3872(11)60005-2
Herman P, Coelho FF, Perini MV, Lupinacci RM, D'Albuquerque LA, Cecconello I. Hepatocellular adenoma: an excellent indication for laparoscopic liver resection. HPB (Oxford) 2012; 14 (6): 390–395.
doi: 10.1111/j.1477-2574.2012.00463.x
Giuliani A, Migliaccio C, Ceriello A, Aragiusto G, La Manna G, Calise F. Laparoscopic vs. open surgery for treating benign liver lesions: assessing quality of life in the first year after surgery. Updates Surg 2014; 66 (2): 127–33.
doi: 10.1007/s13304-014-0252-5
Kamphues C, Engel S, Denecke T, Bova R, Hippler-Benscheidt M, Puhl G, Neuhaus P, Seehofer D. Safety of liver resection and effect on quality of life in patients with benign hepatic disease: single center experience. BMC Surg 2011; 11: 16.
doi: 10.1186/1471-2482-11-16
Koffron A, Geller D, Gamblin TC, Abecassis M. Laparoscopic liver surgery: Shifting the management of liver tumors. Hepatology 2006; 44 (6): 1694–1700.
doi: 10.1002/hep.21485
Toro A, Gagner M, Di Carlo I. Has laparoscopy increased surgical indications for benign tumors of the liver? Langenbecks Arch Surg 2013; 398 (2): 195–210.
doi: 10.1007/s00423-012-1012-y
Tranchart H, Dagher I. Laparoscopic liver resection: a review. J Visc Surg 2014; 151 (2): 107–115.
doi: 10.1016/j.jviscsurg.2013.10.003
Kim Y, Amini N, He J, Margonis GA, Weiss M, Wolfgang CL, Makary M, Hirose K, Spolverato G, Pawlik TM. National trends in the use of surgery for benign hepatic tumors in the United States. Surgery 2015; 157 (6): 1055–1064.
doi: 10.1016/j.surg.2015.01.015
Aldrighetti L, Ratti F, Cillo U, Ferrero A, Ettorre GM, Guglielmi A, Giuliante F, Calise F; Italian Group of Minimally Invasive Liver Surgery (I GO MILS). Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry. Updates Surg 2017; 69: 271–283.
doi: 10.1007/s13304-017-0489-x
Strasberg SM, Belghiti J, Clavien PA. Terminology committee of the IHPBA. Terminology of liver anatomy and resections. HPB Surg 2000; 2: 333–339.
doi: 10.1016/S1365-182X(17)30755-4
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205–213.
doi: 10.1097/01.sla.0000133083.54934.ae
Torzilli G, Viganò L, Giuliante F, Pinna AD. Liver surgery in Italy. Criteria to identify the hospital units and the tertiary referral centers entitled to perform it. Updates Surg 2015; 67 (2): 201–206.
doi: 10.1007/s13304-015-0314-3
Chung YE, Kim MJ, Kim YE, Park MS, Choi JY, Kim KW. Characterization of incidental liver lesions: comparison of multidetector CT versus Gd-EOB-DTPA-enhanced MR imaging. PLoS One 2013; 8 (6): e66141.
doi: 10.1371/journal.pone.0066141
van Rosmalen BV, Bieze M, Besselink MG, Tanis P, Verheij J, Phoa SS, Busch O, van Gulik TM. Long-term outcomes of resection in patients with symptomatic benign liver tumours. HPB (Oxford) 2016; 18 (11): 908–914.
doi: 10.1016/j.hpb.2016.07.013
Nguyen KT, Gamblin TC, Geller DA. World review of laparoscopic liver resection-2,804 patients. Ann Surg 2009; 250 (5): 831–841.
doi: 10.1097/SLA.0b013e3181b0c4df
Aldrighetti L, Belli G, Boni L, Cillo U, Ettorre G, De Carlis L, Pinna A, Casciola L, Calise F; Italian Group of Minimally Invasive Liver Surgery (I GO MILS). Italian experience in minimally invasive liver surgery: a national survey. Updates Surg 2015; 67: 129–140.
doi: 10.1007/s13304-015-0307-2
Croome KP, Yamashita MH. Laparoscopic vs open hepatic resection for benign and malignant tumors: An updated meta-analysis. Arch Surg 2010; 145 (11): 1109–1118.
doi: 10.1001/archsurg.2010.227
Nguyen KT, Marsh JW, Tsung A, Steel JJ, Gamblin TC, Geller DA. Comparative benefits of laparoscopic vs open hepatic resection: a critical appraisal. Arch Surg 2011; 146 (3): 348–356.
doi: 10.1001/archsurg.2010.248
Komatsu S, Scatton O, Goumard C, Sepulveda A, Brustia R, Perdigao F, Soubrane O. Development Process and Technical Aspects of Laparoscopic Hepatectomy: Learning Curve Based on 15 Years of Experience. J Am Coll Surg 2017; 224 (5): 841–850.
doi: 10.1016/j.jamcollsurg.2016.12.037
Ciria R, Cherqui D, Geller DA, Briceno J, Wakabayashi G. Comparative Short-term Benefits of Laparoscopic Liver Resection: 9000 Cases and Climbing. Ann Surg 2016; 263 (4): 761–777.
doi: 10.1097/SLA.0000000000001413
Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, Corvera C, Weber S, Blumgart LH. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002; 236 (4): 397–406.
doi: 10.1097/00000658-200210000-00001
Ercolani G, Ravaioli M, Grazi GL, Cescon M, Del Gaudio M, Vetrone G, Zanello M, Pinna AD. Use of vascular clamping in hepatic surgery: lessons learned from 1260 liver resections. Arch Surg 2008; 143 (4): 380–387.
doi: 10.1001/archsurg.143.4.380
Giuliante F, Ardito F. Minimally invasive liver surgery in a hepato-biliary unit: learning curve and indications. Updates Surg 2015; 67 (2): 201–206.
doi: 10.1007/s13304-015-0314-3
Abu Hilal M, Aldrighetti L, Dagher I, Edwin B, Troisi RI, Alikhanov R, Aroori S, Belli G, Besselink M, Briceno J, Gayet B, D'Hondt M, Lesurtel M, Menon K, Lodge P, Rotellar F, Santoyo J, Scatton O, Soubrane O, Sutcliffe R, Van Dam R, White S, Halls MC, Cipriani F, Van der Poel M, Ciria R, Barkhatov L, Gomez-Luque Y, Ocana-Garcia S, Cook A, Buell J, Clavien PA, Dervenis C, Fusai G, Geller D, Lang H, Primrose J, Taylor M, Van Gulik T, Wakabayashi G, Asbun H, Cherqui D. The Southampton Consensus Guidelines for Laparoscopic Liver Surgery: From Indication to Implementation. Ann Surg 2018; 268 (1): 11–18.
doi: 10.1097/SLA.0000000000002524